A New Anticoagulant, Vitamin B6: Results of a Comparative Study with Hydroxychloroquine Sulphate, in vitro

Abstract

THE following drugs inhibit the clotting of human blood in vitro: glutathione, 2,3-dimercaptopropanol, cysteine hydrochjoride1, oxytetracycline, neomycin, streptomycin2, the disodium salt of ethylenediamine tetraacetic acid3, the potassium, salt of ethylenediamine tetraacetic acid4, chloroquine phosphate5, and hydroxychloroquine sulphate6.

References

  1. 1

    Carter, J. R., and Warner, E. D., Amer. J. Physiol., 173, 109 (1953).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. 2

    Braude, A. I., Davey, P., and Siemienski, J., Proc. Soc. Exp. Biol. and Med., 83, 160 (1953).

    CAS  Article  Google Scholar 

  3. 3

    Hadley, G. G., and Larson, N. L., Amer. J. Clin. Path., 23, 613 (1953).

    CAS  Article  Google Scholar 

  4. 4

    Hadley, G. G., and Weiss, S. P., Amer. J. Clin. Path., 25, 1090 (1955).

    CAS  Article  Google Scholar 

  5. 5

    Mandel, E. H., Arch. Derm., 81, 260 (1960).

    CAS  Article  PubMed Central  Google Scholar 

  6. 6

    Mandel, E. H., J. Mt. Sinai Hosp., 29, 71 (1962).

    CAS  Google Scholar 

  7. 7

    Bennett, J. H., and Rees, B. R., Arch. Derm., 75, 181 (1957).

    CAS  Article  Google Scholar 

  8. 8

    Mandel, E. H., N.Y. State J. Med., 63, 2097 (1963).

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

MANDEL, E. A New Anticoagulant, Vitamin B6: Results of a Comparative Study with Hydroxychloroquine Sulphate, in vitro. Nature 200, 590 (1963). https://doi.org/10.1038/200590a0

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing